FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214892719> ?p ?o ?g. }

• W4214892719 endingPage "101178" @default.
• W4214892719 startingPage "101178" @default.
• W4214892719 abstract "Chronic Kidney Disease Stage 5 (CKD-5) imparts a 4-fold increase in minimal trauma fracture with a substantial increase in mortality following hip fracture. Bone disease in CKD is complex, characterised by abnormal levels of PTH, calcium, phosphate, ALP, and vitamin D, manifesting as a condition known as CKD-Mineral and Bone Disorder (CKD-MBD). While bisphosphonates (BPs) are widely used in the management of osteoporosis, their therapeutic role when end-stage renal function and bone disease co-exist remains unclear. This 15-year retrospective cohort study examines the long-term use of BPs in CKD-4 and -5 patients receiving no renal replacement therapy, haemodialysis and renal transplant in a tertiary centre in Sydney, Australia. In multivariate regression adjusting for age, baseline bone mineral density (BMD) and history of fracture, BP use was associated with net gain in lumbar spine bone density in renal transplant recipients over a mean treatment period of 3.5 years (net annual BMD gain of 0.039 g/cm2, p = 0.005). No such benefit was seen in hip BMD in CKD subjects. Regardless of transplant status, CKD patients treated with BPs had no improvement in hip BMD with a general decline in hip BMD across both groups during the study period (hip BMD: transplant recipients decline 0.024 ± 0.81 g/cm2, non-transplant CKD patients decline 0.055 ± 0.84 g/cm2). BP therapy did not result in significant changes in biochemical parameters (ALP, PTH, and phosphate) and no serious adverse effects were detected in association with BP use. In particular, kidney function was not affected by BPs post-transplant (eGFR = 43 ± 29 ml/min/1.73 m2, p = 0.80). BPs preserved lumbar spine bone density in kidney transplant recipients but did not prevent declines in hip bone mineral density in either transplant patients or those with CKD-4 and -5.There remains a lack of clarity of the risks vs. benefits of bone-sparing pharmacotherapy in chronic kidney disease Stages 4 and 5. This single-centre 15-year retrospective data analysis showed that bisphosphonates are not associated with any detectable serious adverse effects in CKD-4 and -5 and effective at mitigating lumbar spine bone loss in kidney transplant patients." @default.
• W4214892719 created "2022-03-05" @default.
• W4214892719 creator A5001026176 @default.
• W4214892719 creator A5005082975 @default.
• W4214892719 creator A5043698558 @default.
• W4214892719 creator A5066999906 @default.
• W4214892719 creator A5082276935 @default.
• W4214892719 creator A5087506508 @default.
• W4214892719 date "2022-06-01" @default.
• W4214892719 modified "2023-09-26" @default.
• W4214892719 title "Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experience" @default.
• W4214892719 cites W1500101503 @default.
• W4214892719 cites W1982379075 @default.
• W4214892719 cites W2005359013 @default.
• W4214892719 cites W2016619753 @default.
• W4214892719 cites W2021091013 @default.
• W4214892719 cites W2029915743 @default.
• W4214892719 cites W2033727062 @default.
• W4214892719 cites W2039397162 @default.
• W4214892719 cites W2046529733 @default.
• W4214892719 cites W2083161225 @default.
• W4214892719 cites W2085739273 @default.
• W4214892719 cites W2114549634 @default.
• W4214892719 cites W2124019650 @default.
• W4214892719 cites W2158222136 @default.
• W4214892719 cites W2168492271 @default.
• W4214892719 cites W2170998246 @default.
• W4214892719 cites W2229373342 @default.
• W4214892719 cites W2605441623 @default.
• W4214892719 cites W2606034293 @default.
• W4214892719 cites W2606172579 @default.
• W4214892719 cites W2700576091 @default.
• W4214892719 cites W2747160902 @default.
• W4214892719 cites W2764266869 @default.
• W4214892719 cites W2792112123 @default.
• W4214892719 cites W2987621172 @default.
• W4214892719 cites W2998093708 @default.
• W4214892719 cites W3012092983 @default.
• W4214892719 cites W3117441781 @default.
• W4214892719 doi "https://doi.org/10.1016/j.bonr.2022.101178" @default.
• W4214892719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35281213" @default.
• W4214892719 hasPublicationYear "2022" @default.
• W4214892719 type Work @default.
• W4214892719 citedByCount "0" @default.
• W4214892719 crossrefType "journal-article" @default.
• W4214892719 hasAuthorship W4214892719A5001026176 @default.
• W4214892719 hasAuthorship W4214892719A5005082975 @default.
• W4214892719 hasAuthorship W4214892719A5043698558 @default.
• W4214892719 hasAuthorship W4214892719A5066999906 @default.
• W4214892719 hasAuthorship W4214892719A5082276935 @default.
• W4214892719 hasAuthorship W4214892719A5087506508 @default.
• W4214892719 hasBestOaLocation W42148927191 @default.
• W4214892719 hasConcept C124490489 @default.
• W4214892719 hasConcept C126322002 @default.
• W4214892719 hasConcept C126894567 @default.
• W4214892719 hasConcept C141071460 @default.
• W4214892719 hasConcept C159641895 @default.
• W4214892719 hasConcept C170033053 @default.
• W4214892719 hasConcept C2776541429 @default.
• W4214892719 hasConcept C2776886416 @default.
• W4214892719 hasConcept C2778063415 @default.
• W4214892719 hasConcept C2778653478 @default.
• W4214892719 hasConcept C2779329777 @default.
• W4214892719 hasConcept C3019040382 @default.
• W4214892719 hasConcept C71924100 @default.
• W4214892719 hasConceptScore W4214892719C124490489 @default.
• W4214892719 hasConceptScore W4214892719C126322002 @default.
• W4214892719 hasConceptScore W4214892719C126894567 @default.
• W4214892719 hasConceptScore W4214892719C141071460 @default.
• W4214892719 hasConceptScore W4214892719C159641895 @default.
• W4214892719 hasConceptScore W4214892719C170033053 @default.
• W4214892719 hasConceptScore W4214892719C2776541429 @default.
• W4214892719 hasConceptScore W4214892719C2776886416 @default.
• W4214892719 hasConceptScore W4214892719C2778063415 @default.
• W4214892719 hasConceptScore W4214892719C2778653478 @default.
• W4214892719 hasConceptScore W4214892719C2779329777 @default.
• W4214892719 hasConceptScore W4214892719C3019040382 @default.
• W4214892719 hasConceptScore W4214892719C71924100 @default.
• W4214892719 hasLocation W42148927191 @default.
• W4214892719 hasLocation W42148927192 @default.
• W4214892719 hasLocation W42148927193 @default.
• W4214892719 hasLocation W42148927194 @default.
• W4214892719 hasOpenAccess W4214892719 @default.
• W4214892719 hasPrimaryLocation W42148927191 @default.
• W4214892719 hasRelatedWork W113810927 @default.
• W4214892719 hasRelatedWork W2073151133 @default.
• W4214892719 hasRelatedWork W2083201027 @default.
• W4214892719 hasRelatedWork W2110400973 @default.
• W4214892719 hasRelatedWork W2124139470 @default.
• W4214892719 hasRelatedWork W2185124988 @default.
• W4214892719 hasRelatedWork W2364811261 @default.
• W4214892719 hasRelatedWork W2472409292 @default.
• W4214892719 hasRelatedWork W2570861097 @default.
• W4214892719 hasRelatedWork W4226471102 @default.
• W4214892719 hasVolume "16" @default.
• W4214892719 isParatext "false" @default.
• W4214892719 isRetracted "false" @default.
• W4214892719 workType "article" @default.